Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03352245 · ClinicalTrials.gov registry record · NA
Feasibility of an Activity Regimen in Patients With Advanced Stage Lung Cancer
A NA study, sponsored by Yale University.
- Completed
- Registry status
- NA
- Development phase
- 40
- Enrollment target
NCT03352245 is a NA study that has completed, run by Yale University. The registered enrollment target is 40 participants.
The verdict
NCT03352245, a NA study, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
Study Summary
The investigators will evaluate the feasibility of implementing a low-intensity, patient-centered activity regimen (PCAR) that prioritizes education and communication over a 12-week period in advanced stage lung cancer patients. The primary outcomes will include number of patients increasing their overall step count over the study period and adherence to step count recommendations. Secondary outcomes will include quality of life (QoL), dyspnea, and depression scores before and after the intervention as well as a patient feedback questionnaire (to guide further interventions). The goals are to increase overall step count and obtain adherence of \>50% of participants. The investigators will also assess whether the physical activity regimen influences markers of inflammation and glucose control and novel markers of cancer.
Interventions
- BEHAVIORAL Prescribed Activity
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2018-11-26 |
| Est. Completion | 2020-05-24 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03352245
The ClinicalTrials.gov registry entry for NCT03352245 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Prescribed Activity is the first listed.
NCT03352245 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03352245 about?
NCT03352245 is a clinical study titled "Feasibility of an Activity Regimen in Patients With Advanced Stage Lung Cancer". The investigators will evaluate the feasibility of implementing a low-intensity, patient-centered activity regimen (PCAR) that prioritizes education and communication over a 12-week period in advanced stage lung cancer patients. The primary outcomes will include number of patients increasing their o...
What is the current status of trial NCT03352245?
This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2018-11-26. Estimated completion is 2020-05-24.
What interventions are being tested in trial NCT03352245?
The interventions under investigation include: Prescribed Activity (BEHAVIORAL).
Who is sponsoring clinical trial NCT03352245?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.